HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adriana Santos Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

1/2022Impact of Nutritional Status on Survival in Head and Neck Cancer Patients After Total Laryngectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adriana Santos Research Topics

Disease

2Neoplasms (Cancer)
12/2010 - 09/2006
2Carcinoma (Carcinomatosis)
07/2004 - 01/2003
2Infections
01/2003 - 08/2002
1Weight Loss (Weight Reduction)
01/2022
1Malnutrition (Nutritional Deficiencies)
01/2022
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Hypoalbuminemia
01/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2022
1Hemorrhage
11/2014
1Congenital Abnormalities (Deformity)
11/2014
1Diarrhea
12/2010
1Melanoma (Melanoma, Malignant)
09/2006
1Multiple Myeloma
09/2006
1Disease Progression
09/2006
1Gastroesophageal Reflux (GERD)
07/2004
1Achlorhydria (Hypochlorhydria)
07/2004
1Gastritis
10/2002

Drug/Important Bio-Agent (IBA)

1Indicators and Reagents (Reagents)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
11/2014
1Warfarin (Coumadin)FDA LinkGeneric
11/2014
1Apoptosis Regulatory ProteinsIBA
09/2006
1oblimersen (G3139)IBA
09/2006
1Antisense OligonucleotidesIBA
09/2006
1CytokinesIBA
07/2004
1InterleukinsIBA
07/2004
1AntibodiesIBA
01/2003
1EnzymesIBA
01/2003
1ImmunosorbentsIBA
01/2003
1Clarithromycin (Biaxin)FDA LinkGeneric
10/2002
1AntralIBA
10/2002
1carbol-fuchsin solutionIBA
08/2002
1UreaseIBA
08/2002

Therapy/Procedure

2Radiotherapy
01/2022 - 12/2010
2Drug Therapy (Chemotherapy)
12/2010 - 09/2006
1Salvage Therapy
01/2022
1Laryngectomy
01/2022
1Neck Dissection (Radical Neck Dissection)
01/2022
1Therapeutics
09/2006